BioCentury
ARTICLE | Clinical News

Panflu pandemic Influenza vaccine regulatory update

July 13, 2009 7:00 AM UTC

China's State Food and Drug Administration (SFDA) approved a revised drug supplementary application to expand the label of Panflu H1N1 pandemic influenza vaccine to include patients ages 60 and over. ...